Morgan Stanley’s Nuveen New York Tax-Free Income Portfolio NXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-92,885
Closed -$1.12M 8441
2025
Q4
$1.12M Buy
92,885
+5,710
+7% +$69K ﹤0.01% 5121
2025
Q3
$1.05M Buy
87,175
+16,029
+23% +$187K ﹤0.01% 5152
2025
Q2
$827K Sell
71,146
-7,989
-10% -$91.9K ﹤0.01% 5205
2025
Q1
$935K Sell
79,135
-3,471
-4% -$40.6K ﹤0.01% 5031
2024
Q4
$938K Buy
82,606
+9,820
+13% +$117K ﹤0.01% 5124
2024
Q3
$886K Buy
72,786
+278
+0.4% +$3.29K ﹤0.01% 5113
2024
Q2
$848K Buy
72,508
+2,229
+3% +$26K ﹤0.01% 5059
2024
Q1
$818K Sell
70,279
-63,795
-48% -$750K ﹤0.01% 5076
2023
Q4
$1.58M Buy
134,074
+64,160
+92% +$727K ﹤0.01% 5065
2023
Q3
$807K Buy
69,914
+3,578
+5% +$42.7K ﹤0.01% 4920
2023
Q2
$788K Sell
66,336
-6,017
-8% -$71.9K ﹤0.01% 4972
2023
Q1
$872K Sell
72,353
-633
-0.9% -$7.62K ﹤0.01% 4937
2022
Q4
$846K Sell
72,986
-5,503
-7% -$63.2K ﹤0.01% 4956
2022
Q3
$870K Buy
78,489
+1,426
+2% +$16.8K ﹤0.01% 4958
2022
Q2
$898K Sell
77,063
-4,146
-5% -$49.2K ﹤0.01% 5080
2022
Q1
$1M Buy
81,209
+6,065
+8% +$79.3K ﹤0.01% 4996
2021
Q4
$1.02M Buy
75,144
+5,907
+9% +$80.9K ﹤0.01% 5052
2021
Q3
$960K Buy
69,237
+5,204
+8% +$73.9K ﹤0.01% 5069
2021
Q2
$909K Buy
64,033
+6,950
+12% +$98.1K ﹤0.01% 5137
2021
Q1
$828K Buy
57,083
+12,821
+29% +$180K ﹤0.01% 4839
2020
Q4
$628K Sell
44,262
-1,787
-4% -$23.8K ﹤0.01% 4934
2020
Q3
$602K Buy
46,049
+3,978
+9% +$53K ﹤0.01% 4549
2020
Q2
$540K Sell
42,071
-2,628
-6% -$33.6K ﹤0.01% 4559
2020
Q1
$565K Buy
44,699
+1,005
+2% +$13.8K ﹤0.01% 4308
2019
Q4
$618K Buy
43,694
+2,203
+5% +$30.7K ﹤0.01% 4810
2019
Q3
$573K Buy
41,491
+5,332
+15% +$74.1K ﹤0.01% 4617
2019
Q2
$487K Sell
36,159
-2,776
-7% -$37.6K ﹤0.01% 4619
2019
Q1
$526K Buy
38,935
+892
+2% +$11.8K ﹤0.01% 4516
2018
Q4
$489K Buy
38,043
+1,197
+3% +$15.1K ﹤0.01% 4801
2018
Q3
$470K Sell
36,846
-158
-0.4% -$2.03K ﹤0.01% 5037
2018
Q2
$482K Sell
37,004
-2,761
-7% -$35.3K ﹤0.01% 5125
2018
Q1
$516K Buy
39,765
+456
+1% +$5.97K ﹤0.01% 4984
2017
Q4
$536K Buy
39,309
+9,617
+32% +$132K ﹤0.01% 4944
2017
Q3
$416K Buy
29,692
+1,274
+4% +$17.9K ﹤0.01% 4986
2017
Q2
$399K Buy
28,418
+1,772
+7% +$24.5K ﹤0.01% 4945
2017
Q1
$364K Buy
26,646
+2,298
+9% +$30.8K ﹤0.01% 5020
2016
Q4
$322K Sell
24,348
-3,584
-13% -$48.8K ﹤0.01% 5157
2016
Q3
$409K Buy
27,932
+3,502
+14% +$51K ﹤0.01% 4635
2016
Q2
$357K Sell
24,430
-6,959
-22% -$100K ﹤0.01% 4615
2016
Q1
$442K Buy
31,389
+24
+0.1% +$335 ﹤0.01% 4526
2015
Q4
$429K Sell
31,365
-13,075
-29% -$174K ﹤0.01% 4647
2015
Q3
$592K Sell
44,440
-7,724
-15% -$102K ﹤0.01% 4497
2015
Q2
$692K Sell
52,164
-32,448
-38% -$440K ﹤0.01% 4480
2015
Q1
$1.2M Buy
84,612
+3,954
+5% +$55.3K ﹤0.01% 3994
2014
Q4
$1.1M Buy
80,658
+2,524
+3% +$34.5K ﹤0.01% 4079
2014
Q3
$1.05M Buy
78,134
+2,482
+3% +$33.5K ﹤0.01% 3991
2014
Q2
$1.02M Sell
75,652
-500
-0.7% -$6.82K ﹤0.01% 4035
2014
Q1
$1.02M Sell
76,152
-149
-0.2% -$2.01K ﹤0.01% 3977
2013
Q4
$1.02M Sell
76,301
-3,355
-4% -$43.3K ﹤0.01% 3927
2013
Q3
$1.04M Buy
79,656
+1,940
+2% +$25K ﹤0.01% 3757
2013
Q2
$1.05M Buy
+77,716
New +$1.11M ﹤0.01% 3694

Morgan Stanley's NXN Position: Q1 2026 in Review

Morgan Stanley sold out of Nuveen New York Tax-Free Income Portfolio (NXN) in Q1 2026, closing a stake of 92,885 shares — an estimated $1.12M sold.

Morgan Stanley first reported a position in NXN in Q2 2013 and held it in 51 quarters. The position peaked at $1.58M in Q4 2023. 0 funds tracked by Wall St. Rank hold NXN as of Q1 2026.

  • Morgan Stanley reported no remaining Nuveen New York Tax-Free Income Portfolio position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 92,885 Nuveen New York Tax-Free Income Portfolio shares in Q1 2026, an estimated $1.12M.
  • Morgan Stanley first reported a position in Nuveen New York Tax-Free Income Portfolio in Q2 2013 and held it in 51 quarters.
  • Morgan Stanley's Nuveen New York Tax-Free Income Portfolio position peaked at $1.58M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Nuveen New York Tax-Free Income Portfolio as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.